Products | Polpharma API

Generics

We manufacture our products by following our customers’ and health authorities’ most stringent requirements. DMF documentation for all our products is prepared in accordance with the latest requirements  of EDQM (CEP), ICH (ASMF in eCTD format), and FDA (US DMF). Material and product testing is performed in line with the European and United States Pharmacopeias.

Search for product

a b c d e f g h i j k l m n o p r s t u v x y z

Filters

API Status

Commercial Pipeline

Therapeutic Category

Alimentary tract & metabolism Antifungal agent Anti-infectives for systemic use Antipyretic, analgesic and anti-inflammatory Antineoplastic & immunomodulating agents Blood & blood forming organs Cardiovascular system Genito-urinary system & sex hormones Injectable Forms Musculo-skeletal system Nervous system Opthalmological preparations Respiratory system Oncology

Available EU DMF/CEP/US DMF

EU DMF CEP US DMF

Injectable Forms

Yes No

Reset filters

API product & pipeline (pdf)

Sort by

Alphabetical Therapeutic Category

Sort:

Alphabetical Therapeutic Category

Status

Therapeutic Category

Polymorphic form

CAS No.

T

Tadalafil

StatusCommercial

Therapeutic CategoryGenito-urinary system & sex hormones

Polymorphic formForm A (form I)

CAS No.171596-29-5
View more
Ticagrelor

StatusPipeline

Therapeutic CategoryBlood & blood forming organs

Polymorphic formForm II

CAS No.274693-27-5
View more
Tolterodine tartrate

StatusCommercial

Therapeutic CategoryGenito-urinary system & sex hormones

Polymorphic formCrystalline Form I

CAS No. 124937-52-6
View more
Topiramate

StatusCommercial

Therapeutic CategoryNervous system

Polymorphic formOrthorhombic structure

CAS No.97240-79-4
View more